How should hypertension be managed in a patient already taking losartan 100 mg daily and propranolol 20 mg twice daily?

Add a Dihydropyridine Calcium Channel Blocker (DHP-CCB) as the Next Step

For a patient already on losartan 100 mg daily and propranolol 20 mg twice daily with uncontrolled hypertension, add a dihydropyridine calcium channel blocker (such as amlodipine 5-10 mg daily) as the third agent. 1

Rationale Based on Current Guidelines

The 2020 International Society of Hypertension guidelines provide a clear stepwise algorithm for hypertension management 1:

Standard progression for non-Black patients:

• Step 1: Low-dose ACE inhibitor/ARB (losartan is already at maximum 100 mg)
• Step 2: Add DHP-CCB
• Step 3: Increase to full doses
• Step 4: Add thiazide/thiazide-like diuretic
• Step 5: Add spironolactone or alternatives

Your patient is currently on:

• Losartan 100 mg (maximum dose per FDA labeling) 2
• Propranolol 20 mg BID (40 mg total daily - this is a non-standard agent in the ISH algorithm)

Why DHP-CCB is the Correct Next Step

The propranolol represents a deviation from guideline-recommended therapy. Beta-blockers are not first-line agents for uncomplicated hypertension and are relegated to step 5 in the ISH algorithm (after ARB, DHP-CCB, and thiazide diuretic) 1. The 2018 ACC/AHA guidelines similarly state that beta-blockers are "not recommended as first-line agents unless the patient has IHD or HF" 3.

Following the evidence-based algorithm, you should:

1. Add a DHP-CCB (amlodipine 5-10 mg, nifedipine extended-release, or felodipine)
2. Consider whether propranolol is truly indicated (does the patient have coronary artery disease, heart failure, or another specific indication?)

Target Blood Pressure

Aim for BP <130/80 mmHg in most patients 1. The 2024 ESC guidelines reinforce this target 4. Achieve this within 3 months of treatment adjustment 1.

Addressing the Propranolol Issue

Critical consideration: Propranolol 20 mg BID (40 mg total) is a relatively low dose. If there's no compelling indication (post-MI, heart failure, atrial fibrillation, migraine prophylaxis), consider:

• Replacing propranolol with the guideline-recommended DHP-CCB
• If propranolol must continue for a specific indication, recognize you're using a non-standard regimen and still add the DHP-CCB as your third agent

The combination of ARB + DHP-CCB is well-validated and appears in multiple guidelines as a preferred combination 5, 4.

If Blood Pressure Remains Uncontrolled

After adding DHP-CCB, if BP remains elevated:

1. Ensure full doses of both losartan (100 mg) and DHP-CCB (amlodipine 10 mg) 1
2. Add a thiazide-like diuretic (chlorthalidone 12.5-25 mg or indapamide 1.25-2.5 mg preferred over hydrochlorothiazide) 1
3. Check medication adherence - this is a common cause of apparent treatment resistance 1
4. If still uncontrolled on three agents, add spironolactone 25-50 mg daily (if no contraindications like significant CKD or hyperkalemia) 4, 3

Important Caveats

Avoid increasing losartan beyond 100 mg daily - this is the maximum FDA-approved dose for hypertension 2. Research shows that increasing both losartan and hydrochlorothiazide doses simultaneously can be beneficial 6, but losartan monotherapy above 100 mg is not supported.

Monitor for:

• Hyperkalemia (ARB + spironolactone if you reach step 4)
• Peripheral edema (DHP-CCB side effect)
• Renal function changes
• Orthostatic hypotension, especially if patient is elderly

Consider single-pill combinations to improve adherence - losartan/amlodipine combinations are available and simplify the regimen 1.